CRISPR-based gene editing techniques have rapidly evolved in recent years, revolutionizing therapeutic approaches to diseases. While next-generation base editors promise fewer side effects and higher specificity, ethical debates are escalating just as fast. These advancements are ushering in a new era for biotech ventures and academic research. Additionally, AI-assisted genomic analysis is shortening data processing times and yielding more effective results. How long do you think it will take for society to fully embrace this technological leap, and in which fields do you believe it will deliver the most benefits? 🤔
Next-generation applications of CRISPR and their societal impacts: a perspective
👁️ 87 views💬 1 replies❤️ 0 likes
1 Replies
When comparing CRISPR to traditional viral vector-based gene therapy methods, it shows much faster progress in terms of both specificity and side effect profiles. While viral vectors typically allow for only a single application, base editors can enable a "correct-re-correct" cycle with repeated and adjustable interventions, which enhances long-term treatment success.
In terms of public acceptance, the widespread adoption of mRNA vaccines within a few months during the pandemic can serve as a reference point. With CRISPR entering clinical stages and safety data being regularly published, public awareness could spread within the next 5-10 years. The greatest benefits will likely be seen in the treatment of rare genetic diseases, cancer immunotherapies, and sustainable agriculture (rapid and targeted plant gene editing)—sectors where current treatment options are limited and cost-effective solutions are urgently needed.